Cargando…

Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6

[Image: see text] Little is known about the biological and structural features that govern the isoform selectivity for class I histone deacetylases (HDACs) over HDAC6. In addition to that for known inhibitors, like benzamides, psammaplin A, and cyclodepsipeptide-derived thiols, selectivity was also...

Descripción completa

Detalles Bibliográficos
Autores principales: Traoré, Mohamed D. M., Zwick, Vincent, Simões-Pires, Claudia A., Nurisso, Alessandra, Issa, Mark, Cuendet, Muriel, Maynadier, Marjorie, Wein, Sharon, Vial, Henri, Jamet, Helene, Wong, Yung-Sing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044785/
https://www.ncbi.nlm.nih.gov/pubmed/30023639
http://dx.doi.org/10.1021/acsomega.6b00481
_version_ 1783339541708406784
author Traoré, Mohamed D. M.
Zwick, Vincent
Simões-Pires, Claudia A.
Nurisso, Alessandra
Issa, Mark
Cuendet, Muriel
Maynadier, Marjorie
Wein, Sharon
Vial, Henri
Jamet, Helene
Wong, Yung-Sing
author_facet Traoré, Mohamed D. M.
Zwick, Vincent
Simões-Pires, Claudia A.
Nurisso, Alessandra
Issa, Mark
Cuendet, Muriel
Maynadier, Marjorie
Wein, Sharon
Vial, Henri
Jamet, Helene
Wong, Yung-Sing
author_sort Traoré, Mohamed D. M.
collection PubMed
description [Image: see text] Little is known about the biological and structural features that govern the isoform selectivity for class I histone deacetylases (HDACs) over HDAC6. In addition to that for known inhibitors, like benzamides, psammaplin A, and cyclodepsipeptide-derived thiols, selectivity was also observed for naturally occurring cyclopeptide HDAC inhibitors with an aliphatic flexible linker and ketonelike zinc-binding group (ZBG). The present study reports that this isoform selectivity is mainly due to the linker and ZBG, as replacement of the cyclopeptide cap region by a simple aniline retained class I HDAC isoform selectivity toward HDAC6 in enzymatic assays. The best cyclopeptide-free analogues preserved efficacy against Plasmodium falciparum and cancer cell lines. Molecular modeling provided hypotheses to explain this selectivity and suggests different behaviors of the flexible linker on HDAC1 and HDAC6 pockets, which may influence, on the basis of the strength of the ZBG, its coordination with the zinc ion.
format Online
Article
Text
id pubmed-6044785
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-60447852018-07-16 Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6 Traoré, Mohamed D. M. Zwick, Vincent Simões-Pires, Claudia A. Nurisso, Alessandra Issa, Mark Cuendet, Muriel Maynadier, Marjorie Wein, Sharon Vial, Henri Jamet, Helene Wong, Yung-Sing ACS Omega [Image: see text] Little is known about the biological and structural features that govern the isoform selectivity for class I histone deacetylases (HDACs) over HDAC6. In addition to that for known inhibitors, like benzamides, psammaplin A, and cyclodepsipeptide-derived thiols, selectivity was also observed for naturally occurring cyclopeptide HDAC inhibitors with an aliphatic flexible linker and ketonelike zinc-binding group (ZBG). The present study reports that this isoform selectivity is mainly due to the linker and ZBG, as replacement of the cyclopeptide cap region by a simple aniline retained class I HDAC isoform selectivity toward HDAC6 in enzymatic assays. The best cyclopeptide-free analogues preserved efficacy against Plasmodium falciparum and cancer cell lines. Molecular modeling provided hypotheses to explain this selectivity and suggests different behaviors of the flexible linker on HDAC1 and HDAC6 pockets, which may influence, on the basis of the strength of the ZBG, its coordination with the zinc ion. American Chemical Society 2017-04-20 /pmc/articles/PMC6044785/ /pubmed/30023639 http://dx.doi.org/10.1021/acsomega.6b00481 Text en Copyright © 2017 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Traoré, Mohamed D. M.
Zwick, Vincent
Simões-Pires, Claudia A.
Nurisso, Alessandra
Issa, Mark
Cuendet, Muriel
Maynadier, Marjorie
Wein, Sharon
Vial, Henri
Jamet, Helene
Wong, Yung-Sing
Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
title Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
title_full Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
title_fullStr Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
title_full_unstemmed Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
title_short Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
title_sort hydroxyl ketone-based histone deacetylase inhibitors to gain insight into class i hdac selectivity versus that of hdac6
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044785/
https://www.ncbi.nlm.nih.gov/pubmed/30023639
http://dx.doi.org/10.1021/acsomega.6b00481
work_keys_str_mv AT traoremohameddm hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT zwickvincent hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT simoespiresclaudiaa hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT nurissoalessandra hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT issamark hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT cuendetmuriel hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT maynadiermarjorie hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT weinsharon hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT vialhenri hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT jamethelene hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6
AT wongyungsing hydroxylketonebasedhistonedeacetylaseinhibitorstogaininsightintoclassihdacselectivityversusthatofhdac6